Journal of Medicinal Chemistry · 2015 · 16 citations · 19 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryLead OptimizationMolecular PharmacologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismEnzyme InductionHepatic Drug MetabolismHit-to-lead OptimizationLead DiscoveryCyp1a2 Drug MetabolismCytochrome P450 1A2Cytochrome P450 Enzyme ActivityCytochrome P450 Enzyme InductionCytochrome P450 Expression RegulationCytochrome P450 Structure-function RelationshipsEarly Drug DiscoveryInduction In Hepatocytes
This article describes the finding of substantial upregulation of mRNA and enzymes of the cytochrome P450 1A family during a lead optimization campaign for small molecule S1P1 agonists. Fold changes in mRNA up to 10,000-fold for CYP1A1 in vivo in rat and cynomolgus monkey and up to 45-fold for CYP1A1 and CYP1A2 in vitro in rat and human hepatocytes were observed. Challenges observed with correlating induction in vitro and induction in vivo resulted in the implementation of a short, 4 day in vivo screening study in the rat which successfully identified noninducers. Subtle structure-activity relationships in this series of S1P1 agonists are described extending beyond planarity and lipophilicity, and the impact and considerations of AhR and CYP1A induction in the context of drug development are discussed.
19
Marguerite A. Butler, M. Iwasaki, F. Peter Guengerich et al. · Proceedings of the National Academy of Sciences · 1989 · 638 citations · Full text
Medicine, Pharmacology, Toxicology +17
Stefania Aiello, Geoffrey Wells, Erica L. Stone et al. · Journal of Medicinal Chemistry · 2008 · 336 citations · Full text
Classification Analysis of P-Glycoprotein Substrate Specificity
Remigijus Didžiapetris, Pranas Japertas, Alex Avdeef et al. · Journal of drug targeting · 2003 · 256 citations
Wenyue Hu, Claudio Sorrentino, Michael S. Denison et al. · Molecular Pharmacology · 2007 · 221 citations
Pharmacy, Pharmacology, Toxicology +17